Phenacaine

Phenacaine

SCHEMBL24365

CCOc1ccc(/N=C(\C)Nc2ccc(OCC)cc2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SCN1A P35498 1/20 1.00
SCN2A Q99250 1/20 1.00
SCN3A Q9NY46 1/20 1.00
KMT2A Q03164 2/20 0.60
MEN1 O00255 1/20 0.60
LMNA P02545 1/20 0.60
CYP1A2 P05177 1/20 0.60
TDP1 Q9NUW8 1/20 0.60
ADRA2A P08913 4/20 0.58
MAPT P10636 5/20 0.57
POLB P06746 1/20 0.56
ALDH1A1 P00352 2/20 0.54
FAAH O00519 1/20 0.54
GAA P10253 1/20 0.51
MAPK1 P28482 1/20 0.51
KDM4E B2RXH2 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenacaine SCHEMBL16070026 1.00 SCN1A (1.00) SCN1ASCN2ASCN3AKMT2AMEN1
Phenacaine SCHEMBL24364 0.98 SCN1A (0.97) SCN1ASCN2ASCN3AKMT2AMEN1
Phenacaine SCHEMBL30185782 0.97 SCN1A (0.94) SCN1ASCN2ASCN3AKMT2AMEN1
Phenacaine SCHEMBL1652314 0.97 SCN1A (0.94) SCN1ASCN2ASCN3AKMT2AMEN1
SCHEMBL11234205 0.82 ADRA2A (0.83) SCN1ASCN2ASCN3AADRA2AALDH1A1
SCHEMBL9804078 0.81 SCN1A (0.68) SCN1ASCN2ASCN3AKMT2AMEN1
SCHEMBL9804085 0.81 SCN1A (0.68) SCN1ASCN2ASCN3AKMT2AMEN1
SCHEMBL8047968 0.78 ADRA2A (0.69) SCN1ASCN2ASCN3AKMT2AMEN1
SCHEMBL19272266 0.78 KMT2A (0.81) SCN1ASCN2ASCN3AKMT2AMEN1
SCHEMBL17471481 0.77 SCN1A (0.63) SCN1ASCN2ASCN3AKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2545 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260115156-A1 INJECTABLE COMPOSITION INCLUDING HYDROGEL CONTAINING ANESTHETIC AGENT UNIV KOREA RES & BUS FOUND (KR) 2026-04-30 US claimed
WO-2025235864-A1 COATED NEEDLE ADMINISTRATION SYSTEMS EVOLUS, INC. (US) 2025-11-13 WO claimed
US-20250319025-A9 COMPOSITIONS COMPRISING MODIFIED PHOSPHOLIPIDS AND USES THEREOF THE CHILDREN'S MEDICAL CENTER CORPORATION (US) 2025-10-16 US claimed
EP-4578441-A1 TREATMENT OF LOCALIZED PAIN PlantTec Medical GmbH (DE) 2025-07-02 EP claimed
US-20250205278-A1 METHODS AND COMPOSITIONS FOR WOUND HEALING ABBOTT NICHOLAS L (US) 2025-06-26 US claimed
WO-2025128639-A1 HYDROGELS COMPRISING PROTEIN-STABILIZED NANOPARTICLES FOR EXTENDED RELEASE THE CHILDREN'S MEDICAL CENTER CORPORATION (US) 2025-06-19 WO claimed
US-12329856-B2 Crosslinked hyaluronic acid composition with local anesthetics BIOPOLIMERI S.R.L. (IT) 2025-06-17 US claimed
US-20250186364-A1 COMBINATION OF ANTISPASMODIC AND ANESTHETIC AGENTS FOR TOPICAL PRODUCTS AND THEIR METHOD OF USE PRIMA INNOVATIONS, LLC 2025-06-12 US claimed
WO-2025075976-A2 METHYL-BRANCHED LIPOSOMES FOR SUSTAINED DRUG DELIVERY THE CHILDREN'S MEDICAL CENTER CORPORATION (US) 2025-04-10 WO claimed
EP-4362994-B1 CROSSLINKED HYALURONIC ACID COMPOSITION WITH LOCAL ANESTHETICS BIOPOLIMERI S R L (IT) 2025-03-12 EP claimed
EP-0868914-A1 Pharmaceutical composition for the control and treatment of anorectal and colonic diseases PANACEA BIOTEC LIMITED (IN) 1998-10-07 EP claimed
WO-1998041171-A1 CONTROLLED RELEASE OF PHARMACEUTICALS IN THE ANTERIOR CHAMBER OF THE EYE GALIN MILES A (US) 1998-09-24 WO claimed
EP-0850054-A1 FORMULATIONS OF HALOALKYLAMINES AND LOCAL ANAESTHETICS AND METHODS FOR THE TREATMENT OF REFLEX SYMPATHETIC DYSTROPHY (RSD) NEW YORK MEDICAL COLLEGE (US) 1998-07-01 EP claimed
WO-1997027750-A1 AQUEOUS CAFFEINE DOSAGE FORMS ANTHEA ENTERPRISES INCORPORATED (US) 1997-08-07 WO claimed
WO-1997007793-A1 FORMULATIONS OF HALOALKYLAMINES AND LOCAL ANAESTHETICS AND METHODS FOR THE TREATMENT OF REFLEX SYMPATHETIC DYSTROPHY (RSD) NEW YORK MEDICAL COLLEGE (US) 1997-03-06 WO claimed
EP-0471135-A2 Compositions, medicaments and methods for the promotion of hair growth Hallam, Kenneth M. (US) 1992-02-19 EP claimed
EP-0126684-B1 DRUG DELIVERY SYSTEM UTILIZING THERMOSETTING GELS MERCK & CO. INC. (US) 1991-08-28 EP claimed
US-4636387-A MODIFIED WITH 2-AMINOPYRIDINE, BENOXINATE, NAEPAINE AND PHENACAINE RESEARCH CORPORATION (US) 1987-01-13 US claimed
EP-0126684-A2 Drug delivery system utilizing thermosetting gels MERCK & CO. INC. (US) 1984-11-28 EP claimed
US-4474751-A SUSTAINED RELEASE USING AN ALKYLENEDIAMINE-MODIFIED ETHYLENE OXIDE-PROPYLENE OXIDE COPOLYMER MERCK & CO., INC. (US) 1984-10-02 US claimed